
FDA advisers vote to include an Omicron-specific component for a coronavirus booster in the US
CNN
The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.
Twenty-one voting members of the FDA's independent committee voted on the question:
"Does the committee recommend inclusion of a SARS-CoV-2 Omicron component for COVID-19 booster vaccines in the United States?"
More Related News